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Peptidyl-Prolyl Isomerase 1 Regulates Ca2+ Handling by Modulating
Sarco(Endo)Plasmic Reticulum Calcium ATPase and Na2+/Ca2+
Exchanger 1 Protein Levels and Function
Veronica Sacchi, PhD; Bingyan J. Wang, MS; Dieter Kubli, PhD; Alexander S. Martinez, BS; Jung-Kang Jin, PhD; Roberto Alvarez, Jr, BS;
Nirmala Hariharan, PhD; Christopher Glembotski, PhD; Takafumi Uchida, PhD; James S. Malter, MD; Yijun Yang, PhD; Polina Gross,
PhD; Chen Zhang, MD; Steven Houser, PhD; Marcello Rota, PhD; Mark A. Sussman, PhD
Background-—Aberrant Ca2+ handling is a prominent feature of heart failure. Elucidation of the molecular mechanisms responsible
for aberrant Ca2+ handling is essential for the development of strategies to blunt pathological changes in calcium dynamics. The
peptidyl-prolyl cis-trans isomerase peptidyl-prolyl isomerase 1 (Pin1) is a critical mediator of myocardial hypertrophy development
and cardiac progenitor cell cycle. However, the inﬂuence of Pin1 on calcium cycling regulation has not been explored. On the basis
of these ﬁndings, the aim of this study is to deﬁne Pin1 as a novel modulator of Ca2+ handling, with implications for improving
myocardial contractility and potential for ameliorating development of heart failure.
Methods and Results-—Pin1 gene deletion or pharmacological inhibition delays cytosolic Ca2+ decay in isolated cardiomyocytes.
Paradoxically, reduced Pin1 activity correlates with increased sarco(endo)plasmic reticulum calcium ATPase (SERCA2a) and Na2+/
Ca2+ exchanger 1 protein levels. However, SERCA2a ATPase activity and calcium reuptake were reduced in sarcoplasmic reticulum
membranes isolated from Pin1-deﬁcient hearts, suggesting that Pin1 inﬂuences SERCA2a function. SERCA2a and Na2+/Ca2+
exchanger 1 associated with Pin1, as revealed by proximity ligation assay in myocardial tissue sections, indicating that regulation
of Ca2+ handling within cardiomyocytes is likely inﬂuenced through Pin1 interaction with SERCA2a and Na2+/Ca2+ exchanger 1
proteins.
Conclusions-—Pin1 serves as a modulator of SERCA2a and Na2+/Ca2+ exchanger 1 Ca2+ handling proteins, with loss of function
resulting in impaired cardiomyocyte relaxation, setting the stage for subsequent investigations to assess Pin1 dysregulation and
modulation in the progression of heart failure. ( J Am Heart Assoc. 2017;6:e006837. DOI: 10.1161/JAHA.117.006837.)
Key Words: cardiomyocyte • Na+/Ca2+ exchange • peptidyl-prolyl isomerase 1 • sarcoplasmic reticulum Ca2+-ATPase
C a
2+ is a ubiquitous intracellular second messenger
exerting several fundamental roles in the myocardium,
including control of cardiomyocyte mechanical behavior and
programmed cell death, as well as regulation of pathological
hypertrophic remodeling through Ca2+/calmodulin-dependent
kinase II (CaMKII) signaling.1,2 Ca2+-dependent signaling is
highly regulated in cardiomyocytes and determines force of
cardiac muscle contraction. Ca2+ uptake and release is
profoundly altered in failing hearts, resulting in impaired
contractility and fatal cardiac arrhythmias.3,4 Considering the
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crucial role of Ca2+ in regulating cardiac muscle contraction,
much attention has been paid to understanding the role of
defects in Ca2+ regulation in heart failure (HF).4
Impaired sarcoplasmic reticulum (SR) Ca2+ uptake causes
deterioration to both systolic and diastolic heart function.4,5
Ca2+ removal from the cytosol occurs by both sarco(endo)-
plasmic reticulum calcium ATPase (SERCA2a)–mediated
uptake and sarcolemmal extrusion, mainly via Na2+/Ca2+
exchanger 1 (NCX-1). During homeostasis, the amount of
Ca2+ recycled by the SR in the relaxation phase equals the
amount released, and inﬂux of Ca2+ equals the amount
extruded.2 In HF, SERCA2a function is decreased and NCX-1
activity is enhanced, causing impaired relaxation, which leads
to reductions of SR Ca2+ load and cardiomyocyte contractil-
ity.2,4,6 Cardiac contractility was improved in preclinical and
clinical trials by viral overexpression of SERCA2a; it can be
accompanied by arrhythmia.4 As with SERCA2a, additional
therapeutic targets in key pathways that regulate cardiac Ca2+
dynamics can be revealed by unraveling molecular mecha-
nisms regulating Ca2+ cycling proteins.4
Posttranslational modiﬁcations, such as reversible protein
phosphorylation, form the basis of several complex signaling
cascades governing cellular fate during cardiac pathophysio-
logical conditions.7 However, another layer of regulation
beyond binary “on/off” switching mechanisms is added by the
peptidyl cis-to-trans isomerases (PPIases) that tune intensity
and duration of signals by switching the 3-dimensional
conformation of target phosphoproteins.7,8
Peptidyl-prolyl isomerase 1 (Pin1) is a unique PPIase that
selectively promotes the cis-to-trans isomerization on speci-
ﬁc recognition of a major regulatory phosphorylation motif
(Ser/Thr-Pro) belonging to the family of Pro-directed protein
kinases that include protein kinase B (Akt), Proto-oncogene
serine/threonine kinase (Pim-1), cyclin-dependent protein
kinases, and many more canonical cardiac target pro-
teins.7,9–11 Pin1 is a small protein (163 amino acids) but
highly conserved; it is composed of an N-terminal WW
domain that directs Pin1 to appropriate substrates and a
C-terminal PPIase domain that controls target-protein con-
formation switching.9–11 Previous studies identiﬁed Pin1 as
an essential regulator of heart hypertrophy, induced by
transaortic constriction,12 and of the cardiac progenitor cell
cycle.13
PPIase family members other than Pin1 regulate calcium
ion channel function, but the inﬂuence and role of Pin1 in Ca2+
handling regulation remained unaddressed.14 This study
highlights a novel function of Pin1 in the heart as a regulator
of Ca2+ cycling, showing that Pin1 controls Ca2+ handling in
cardiomyocytes by controlling Ca2+ clearance through mod-
ulation of SERCA2a and NCX-1 protein levels and function.
Inclusion of Pin1 as a novel regulator of cardiomyocyte
calcium dynamics opens up novel potential avenues for
molecular interventional approaches to normalize calcium
homeostasis in the pathological myocardium.
Methods
Mice
Pin1+/ and Pin1/ mice were obtained from Dr Takafumi
Uchida (Tohoku University, Miyagi, Japan) and from Dr James
Malter (University of Texas Southwestern, Dallas, TX). Non-
transgenic (wild-type [WT]) C57/B6 mice were used as
controls. Mice enrolled in the study were 6 to 7 months of
age, and no differences in the baseline global phenotype
were observed in nontransgenic and transgenic mice. An
n=5 animals/group was used for the experiment described
in Figure 1, whereas an n=3 animals/group was used for all
other experiments. All animal protocols and studies were
approved by the institutional review board of the Animal
Care and Use Committee at San Diego State University (San
Diego, CA).
Ca2+ Cycling and Contractility Assessment
Left ventricular cardiomyocytes, isolated as previously
described,15,16 were placed in a heated bath at 31°C on the
stage of inverted microscopes for contractility and Ca2+
transients. Cells were bathed continuously with Tyrode
solution containing 1 mmol/L CaCl2, and the myocyte ﬁeld
was stimulated at 1 Hz. Sarcomere shortening was measured
with an IonOptix system, whereas intracellular Ca2+ handling
was assessed in cells loaded with 0.57 lmol/L Fluo-4 AM
Clinical Perspective
What Is New?
• This study reveals a novel role for peptidyl-prolyl isomerase
1 in modulating the expression and function of Ca2+-
handling proteins sarco(endo)plasmic reticulum calcium
ATPase and Na2+/Ca2+ exchanger 1, with peptidyl-prolyl
isomerase 1 loss of function resulting in impaired cardiomy-
ocyte relaxation.
What Are the Clinical Implications?
• Decreased peptidyl-prolyl isomerase 1 activity could con-
tribute to impairment of Ca2+ cycling in the heart, resulting
in diminished contractile function under stress and loss of
inotropic responsiveness in the failing heart. Cardiac-
speciﬁc peptidyl-prolyl isomerase 1 overexpression could
serve as a molecular interventional strategy to normalize
Ca2+ handling within cardiomyocytes laboring under patho-
logical stress.
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with an epiﬂuorescence system. Setups were coupled with
Digidata or DI-155 interface and pClamp or WinDaq software.
Data were analyzed with pClamp or LabChart software. Fluo-4
signals were expressed as normalized ﬂuorescence (F/F0),
where F0 is the diastolic ﬂuorescent level subtracted by the
background signal measured in the region adjacent to the cell,
as described.16,17 To assess Ca2+ cycling in response to short-
term Pin1 inhibition, isolated cardiomyocytes were pretreated
for 2 hours with either Pin1 inhibitor (1 lmol/L juglone) or
water as vehicle control before intracellular Ca2+ handling
measurement at room temperature.
Immunoblot Analysis
Whole heart lysates were prepared by homogenizing tissues in
lysis buffer containing 1 mol/L Tris-HCl (pH 7.4), 5 mol/L
NaCl, 100 mmol/L EDTA, and 100 mmol/L EGTA, supple-
mented with protease and phosphatase inhibitor cocktails
Figure 1. Ca2+ transient decay and time to peak (TTP) shortening and relaxation are delayed in peptidyl-prolyl isomerase 1 (Pin1)/
cardiomyocytes. A and B, Pin1/ cardiac myocytes have delayed Ca2+ transient decay (A) and TTP sarcomere shortening (B), as shown by
representative superimposed traces. For each cell, an average trace of >10 beats is reported. C through E, Ca2+ transient amplitude (C) and TTP
(D) are unchanged in Pin1/ myocytes vs wild type (WT), but Ca2+ transient decay (E) is signiﬁcantly increased by loss of Pin1. WT (n=166 cells
from 5 hearts) and Pin1/ (n=162 cells from 5 hearts) mice are shown. F through H, Sarcomere shortening (F) is unaltered by loss of Pin1,
whereas TTP shortening (G) and relaxation (H) are signiﬁcantly increased in Pin1/ cardiac myocytes. WT (n=106 cells from 5 hearts) and
Pin1/ (n=108 cells from 5 hearts) mice are shown. Data presented as median and interquartile ranges. *P<0.05 (Student t test).
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using a Next Advance bullet blender at 4°C. Tissue
homogenates were transferred to clean tubes, Triton X-100
was added at 1% ﬁnal concentration, and lysates were
incubated on ice for 60 minutes. Homogenates were cen-
trifuged at 16 100g, and supernatants were collected for
further experiments. Adult cardiomyocytes were isolated, as
previously described.18 Cardiomyocytes were treated with
either Pin1 inhibitor (10 nmol/L; or 1 lmol/L juglone) or
water as vehicle control for 2 hours. Afterwards, medium was
removed and isolation buffer containing 1 mol/L Tris-HCl (pH
7.4), 5 mol/L NaCl, 100 mmol/L EDTA, 100 mmol/L EGTA,
and 1% Triton X-100, supplemented with protease and
phosphatase inhibitor cocktails, was added to the cells for
isolating proteins by cell scraping. Tissue and cell lysates
were stored at 80°C until further use. Protein concentration
was determined by Bradford assay using BSA standards and
normalized to the samples having the lowest protein concen-
tration. Proteins lysates were prepared by adding LDS Sample
Buffer with 50 mmol/L dithiothreitol. Samples were boiled for
5 minutes at 70°C to denature proteins. Proteins were
separated by SDS-PAGE (15–20 lg in each gel lane) and
transferred to Immobilon-FL polyvinylidene diﬂuoride mem-
branes. Primary antibodies were incubated overnight in TBS
Blocking Buffer at 4°C, and secondary antibodies were
incubated for 90 minutes at room temperature in blocking
buffer. Fluorescent signals were detected using a Scanner
Odyssey CLx and quantiﬁed using software. Antibodies and
dilutions are listed in Table S1.
In Silico Analysis of SERCA2a and NCX-1 Proteins
to Identify Putative Pin1 Binding Sites
SERCA2a and NCX-1 murine protein sequences were selected
from the Protein National Center for Biotechnology Informa-
tion Database. The accession number for SERCA2a was NP_
033852.1; and for NCX-1, NP_035536.2. The presence of
serine next to a proline is highlighted by a black square,
whereas the presence of a threonine next to a proline is
highlighted by a red square.
Proximity Ligation Assay
Proximity ligation assay was performed as previously
described.12,19–22 Brieﬂy, hearts ﬁxed in 10% formalin were
embedded in parafﬁn, sectioned at a thickness of 4 µm, and
stained for Pin1 and Serca2a/Ncx-1 primary antibodies.
Isolated cardiomyocytes, as described in Immunoblot analysis
section, were ﬁxed in 4% paraformaldehyde and permeabilized
with 0.3% Triton X-100 before proceeding with primary
antibody staining. Signal was detected using Duolink In Situ
Detection Reagent and Probes. Myosin light chain 2 was used
to visualize myocardium. Antibody manufacturers and dilutions
are listed in Table S1. Duolink In Situ Mounting Medium with
40,6-diamidino-2-phenylindole was used to counterstain nuclei
and coverslip. Scans consisted of Z-stack random regions for
each heart analyzed using an SP8 Confocal Microscope using
409 objective. The number of events was quantiﬁed using the
ImageJ particles counting tool in each ﬁeld.
Glutathione S-Transferase and Glutathione
S-Transferase–Pin1 Recombinant Protein
Production
Recombinant glutathione S-transferase (GST) protein was
purchased. The expression plasmid for GST-Pin1 was also
purchased. GST-Pin1 protein was produced8 with minor
adaptation. One Shot Top10 Escherichia coli cells were
transformed and ampliﬁed in Luria-Bertani (LB) medium
containing ampicillin at 100 lg/mL overnight at 37°C, 67 g
overnight. The optical density at 600 optical density was
measured by a biophotometer and adjusted with fresh LB
medium between 0.4 and 0.6 optical density because less
growth or overgrowth will affect future GST-Pin1 protein
expression. LB (400 mL) and 1 mol/L isopropyl b-D-1-
thiogalactopyranoside (400 µL) were added to the culture
and incubated for another 5 hours at 37°C, 67 g. The bacteria
pellets were thereafter obtained by centrifugation at 0°C, 1015
g for 25 minutes. Bacteria pellets were diluted 1:1 in lysis
buffer containing 50 mmol/L Tris-HCl (pH 7.5), 100 mmol/L
NaCl, and 5 mmol/L dithiothreitol, supplemented with pro-
tease and phosphatase inhibitor cocktails. They were lysed by
sonication using 10 short pulses (5–10 seconds), followed by
30-second pauses to reestablish a low temperature. Cell debris
was removed by centrifugation at 0°C, 4872 g for 25 minutes.
GST-Pin1 protein was puriﬁed from crude lysates using the
Pierce GST Spin Puriﬁcation Kit, according to the manufac-
turer’s instructions. Protein expression was conﬁrmed by
immunoblot for GST, as described in the Immunoblot Analysis
subsection of the Methods section.
Pull-Down Assay
Pull-down assay using GST-Pin1 was performed8 with minor
adaptation. Brieﬂy, cardiomyocytes were isolated from WT
mice18 and incubated in 1 mL of lysis buffer containing
50 mmol/L HEPES (pH 7.4), 150 mmol/L NaCl, 10% glycerol,
1% Triton X-100, 1.5 mmol/L MgCl2, 1 mmol/L EGTA,
100 mmol/L NaF, 1 mmol/L Na3VO4, and 1 mmol/L dithio-
threitol, supplemented with protease and phosphatase inhi-
bitor cocktails for 30 minutes at 4°C on a rotator. Cell lysates
were centrifuged at 16 100g for 20 minutes at 4°C to pellet cell
debris, and 200 lL of supernatant was transferred to a clean
1.5-mL tube for each assay. GST or GST-Pin1 fusion protein at
2 lmol/L was added to supernatant, and samples were rotated
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at 4°C for 1 hour. GST beads (20µL) were added to the samples
and rotated at 4°C for 1 hour. GST beads were pelleted by
centrifugation at 9300g and washed 3 times with 1 mL of lysis
buffer. Afterwards, lysis buffer was removed and beads were
resuspended in 20 lL of LDS Sample Buffer with 50 mmol/L
dithiothreitol. Samples were boiled for 5 minutes at 70°C to
denature proteins, GST beadswere pelleted by centrifugation at
9300g, and supernatant was applied to the SDS-PAGE gel.
Immunoblot was performed, as described above, using primary
antibody dilutions listed in Table S1.
SR-Membrane Enrichment
SR-enriched fractions were isolated from WT, Pin1+/, and
Pin1/ hearts, as previously described,23,24 with minor
adaptations. Brieﬂy, myocardium was homogenized in buffer
containing the following: 5 mmol/L HEPES, 250 mmol/L
sucrose , 0.2% sodium azide, and a cocktail of phosphatase and
protease inhibitors. The homogenate was centrifuged at 5500g
for 10 minutes to remove cellular debris. The supernatant was
then transferred to clean tubes and centrifuged at 12 500g for
18 minutes. These pellets were discarded, and the spin was
repeated. Again, the supernatant was transferred to clean tubes
and centrifuged atmaximal speed for 1 hour. These pellets were
resuspended in homogenizing buffer plus 600 mmol/L KCl and
allowed to incubate at 4°C for 30 minutes. This suspension was
then centrifuged at maximal speed for 1 hour. The ﬁnal pellet,
enriched in SR membranes, was resuspended in homogenizing
buffer and stored at 80°C until assayed.
SERCA2a ATPase Activity
SERCA2a Ca2+-dependent ATPase activity was measured on
10 lg/mL of SR preparations using the High Throughput
Colorimetric ATPase assay kit, according to manufacturer’s
instructions. This was done in the presence of 2 lmol/L of
the calcium ionophore A23187 and of an escalating concen-
tration of free Ca2+ (0–0.5–1–2.5–5–8–10 lmol/L). Reac-
tions were incubated for 30 minutes at room temperature.
SERCA-independent Ca2+-ATPase activity was measured in
the presence of 100 nmol/L of thapsigargin and subtracted
from total SR-ATPase activity to calculate speciﬁc SERCA2a-
ATPase hydrolysis activity. The activity of SERCA2a was
calculated as hydrolyzed ATP levels (lmol/L) normalized with
protein content (mg) and reaction time (minutes) from 3
independent experiments.
SR Uptake and Release
Oxalate-supported Ca2+-uptake rates were measured using
the Ca2+ ﬂuorescent dye indo-1, according to published
methods,23,25 with minor adaptation for use on a plate reader
(SPECTRAmax Plus). Immediately before collection of emis-
sion spectra, 25 lg of isolated SR membranes was added to
each well. Baseline reads were collected until ﬂuorescence
was not stable; then, CaCl2 was added to each well to produce
a consistent starting of [Ca2+]f of 3.5 lmol/L. Shortly after
the attainment of a constant [Ca2+]f, 5 mmol/L ATP was
added to each well to initiate Ca2+ uptake. Maximum and
minimum Ca2+-dependent ﬂuorescence was determined after
the Ca2+ uptake reaction by additions of 250 lmol/L of the
Ca2+ chelator EGTA and 1 mmol/L of the CaCl2. 4-Chloro-m-
cresol (20 mmol/L) was added to the assay mixture to
chemically stimulate Ca2+ release in vitro.
Statistical Analysis
Data in Figure 1 were represented as median and interquartile
ranges; in Figures 2 through 5, as meanSEM; and in
Figure 6, as median and interquartile ranges. Statistical
analysis was performed using the unpaired Student t test or
1-way ANOVA, with a Dunnett post-hoc test to compare each
group with a control group using GraphPad Prism version 5.0.
When normality or equal variance was not met, nonparametric
analysis was performed using a Mann-Whitney rank sum
test.16 P<0.05 was considered statistically signiﬁcant.
Results
Ca2+ Transient Decay Is Delayed in Pin1/
Cardiomyocytes
Cardiomyocytes from WT and Pin1/ mice were isolated to
assess the consequences of systemic loss of Pin1 on
cardiomyocyte Ca2+ cycling and contractile function. Repre-
sentative superimposed traces of Ca2+ transients and sarcom-
ere shortening show Pin1/ cardiomyocytes possess delayed
Ca2+ transient decay and slightly longer time to peak compared
with WT cardiomyocytes (Figure 1A and 1B). Quantiﬁcation of
Ca2+ transient decay (Figure 1E), time-to-peak shortening
(Figure 1G), and relaxation (Figure 1H) conﬁrmed a signiﬁcant
delay in Pin1/ cardiomyocytes compared with WT. Ampli-
tude of Ca2+ transient (Figure 1C), TTP Ca2+-Transient (Figure
1D), and contractility (Figure 1F) remain unchanged in Pin1/
cardiomyocytes compared with WT. Collectively, these data
indicate loss of Pin1 impairs cardiomyocyte Ca2+ cycling, which
may play a critical role in supporting systemic hemodynamic
demand in vivo.
SERCA2a and NCX-1 Protein Levels Are Elevated
in Pin1-Deﬁcient Hearts
Ca2+ inﬂux and efﬂux from cardiomyocyte SR and cytosol are
tightly regulated by expression of several proteins and their
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phosphorylation status.4 Because Pin1 inﬂuences protein
expression levels and phosphorylation, the impact of
decreased Pin1 expression on SERCA2a, NCX-1, CaMKII,
phospholamban, L-type Ca2+ channel, and ryanodine receptor
2 protein expression and phosphorylation was assessed using
whole heart lysates harvested from WT, Pin1+/, and Pin1/
mice. Pin1+/ mice express 50% of Pin1 protein compared
with WT,26 and have been included in this study to investigate
Figure 2. Sarco(endo)plasmic reticulum calcium ATPase (SERCA2a) and Na2+/Ca2+ exchanger 1 (NCX-1)
protein levels are elevated in peptidyl-prolyl isomerase 1 (Pin1)–deﬁcient hearts. Immunoblot showing
SERCA2a (A) and NCX-1 (B) levels signiﬁcantly increased in Pin1+/ and Pin1/ hearts compared with wild
type (WT). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. Quantiﬁ-
cation of protein expression below each representative blot shown as n-fold expression/WT. N=3. Data
presented as meanSEM. *P<0.05, †P<0.01 vs WT (1-way ANOVA, followed by Dunnett post-hoc analysis).
Figure 3. Cardiac sarcoplasmic reticulum (SR) Ca2+-ATPase activity and uptake are impaired in peptidyl-prolyl isomerase 1 (Pin1)–deﬁcient
hearts. A, Reduced Ca2+-dependent ATPase activity by puriﬁed Pin1+/ and Pin1/ cardiac SR membranes determined on the basis of release
of inorganic phosphate. Speciﬁcity of SR Ca2+-ATPase activity assessed in the presence of 100 nmol/L of thapsigargin. B and C, SR Ca2+ uptake
(B) reduced in Pin1+/ and Pin1/ isolated SR membranes, whereas SR release (C) was not inﬂuenced by Pin1 loss, as measured using the
Ca2+ ﬂuorescent dye Indo-1. A through C, N=3SEM. *P<0.05, †P<0.01 vs Pin1/; ‡P<0.05, §P<0.01 wild type (WT) vs Pin1+/ (1-way
ANOVA, with Dunnett post-hoc test; A). *P<0.05 WT vs Pin1/, †P<0.05 WT vs Pin1+/ (1-way ANOVA, followed by Dunnett post-hoc test;
B and C).
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phenotypic consequences of partial Pin1 deletion on calcium
handling. SERCA2a protein level was increased 1.5-fold in
Pin1+/ and 1.8-fold in Pin1/ hearts compared with WT
(Figure 2A). NCX-1 protein level was elevated 1.6- and 1.7-
fold in Pin1+/ and Pin1/, respectively, compared with WT
(Figure 2B). In comparison, expression and phosphorylation of
CaMKII, L-type Ca2+ channels, phospholamban (both pSer16
and pThr17), and ryanodine receptor 2 (both pSer2808 and
pSer2814) were unaltered by Pin1 loss (Figure S1A through
S1D). These results indicate Pin1 inﬂuences SERCA2a and
NCX-1 protein levels as a potential explanation to account for
delayed Ca2+ transient decay resolution in isolated cardiomy-
ocytes (Figure 1).
Cardiac SERCA2a Function Is Impaired in
Pin1-Deﬁcient Hearts
Increased SERCA2a protein level correlates with enhanced
Ca2+ uptake, resulting in faster Ca2+ transient decay and
relaxation.4 Paradoxically, loss of Pin1 leads to slowing of Ca2+
transient decay (Figure 1) together with elevated SERCA2a
protein level (Figure 2). To resolve these superﬁcially dis-
crepant observations, SERCA2a ATPase activity and Ca2+
uptake and release from SR membrane–enriched preparations
were measured. Stimulation of Ca2+-dependent SERCA2a
ATPase activity was assessed on the basis of release of
inorganic phosphate. SERCA2a-independent ATPase activity
was evaluated in the presence of SERCA2a inhibitor (thapsi-
gargin) and subtracted from total SERCA2a ATPase activity to
calculate speciﬁc activity. SERCA2a ATPase activity in Pin1+/
and Pin1/ is reduced compared with WT when [Ca2+] is in
the range of 5 to 10 lmol/L (Figure 3A). At a 5 lmol/L Ca2+
concentration, SERCA2a activity was 31.721.25% for WT
samples compared with 23.571.08% for Pin1+/ or
23.330.21% for Pin1/ (P<0.05). At an 8 lmol/L Ca2+
concentration, SERCA2a activity was 51.883.83% for WT
compared with 30.350.19% for Pin1+/ or 31.421.25% for
Pin1/ (P<0.05). At a 10 lmol/L Ca2+ concentration,
Figure 4. Sarco(endo)plasmic reticulum calcium ATPase (SERCA2a) and Na2+/Ca2+ exchanger 1 (NCX-1) interact with peptidyl-prolyl
isomerase 1 (Pin1) in vivo. Pin1 interaction with SERCA2a (A) and NCX-1 (B), as determined by proximity ligation assay (PLA). Number of events
detected on tissue sections stained with both primary antibodies and single primary antibodies are shown on the left panels. Representative
micrographs of PLA showing direct interaction of Pin1 with NCX-1 and SERCA2a (red dots) are presented on the right panels. Heart sections
were also stained with myosin light chain 2 (MYL2; green) and 40,6-diamidino-2-phenylindole (DAPI; blue). N=3. Size bar=25 lm. Data are
meanSEM. *P<0.0001 vs wild-type (WT) NC (1-way ANOVA, followed by Dunnett post-hoc test). NC indicate Negative Control.
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Figure 5. Sarco(endo)plasmic reticulum calcium ATPase (SERCA2a) and Na2+/Ca2+ exchanger 1 (NCX-1)
interaction with peptidyl-prolyl isomerase 1 (Pin1) is disrupted by Pin1 inhibition. A and B, SERCA2a (A) and
NCX-1 (B) interaction with Pin1 determined by proximity ligation assay on isolated wild-type (WT)
cardiomyocytes treated with either Pin1 inhibitor juglone or vehicle control for 2 hours. N=3. C and D,
SERCA2a and NCX-1 protein expression dose dependently accumulates in cardiomyocytes treated with
juglone for 2 hours compared with cardiomyocytes in culture medium (CM). DAPI indicates 40,6-diamidino-
2-phenylindole; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; and MYL2, myosin light chain 2.
*P<0.01 vs WT, †P< 0.001 vs WT.
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SERCA2a activity was 77.291.41% for WT compared with
45.142.61% for Pin1+/ or 41.671.45% for Pin1/
(P<0.01). By ﬂuorimetric assay, the SR membrane Ca2+
uptake rate was reduced 25% in Pin1+/ and Pin1/
compared with WT (Figure 3B). Rate of Ca2+ uptake was
83.225.3 nmol/L per mg SR membrane/min in WT, but
decreased to 62.364.22 nmol/L per mg SR membrane/min
in Pin1+/ or 66.1073.717 nmol/L per mg SR membrane/
min in Pin1/ (P<0.05; Figure 3B). SR uptake was compa-
rably inhibited by thapsigargin in all WT, Pin1+/, and Pin1/
samples, conﬁrming reduction in SR Ca2+ uptake in Pin1+/
and Pin1/ membranes with diminished SERCA2a function.
In comparison, SR-mediated Ca2+ release was not affected by
Pin1 reduction (Figure 3C). Overall, these results indicate
SERCA2a ATPase activity and calcium reuptake are reduced by
loss of Pin1.
SERCA2a and NCX-1 Interact With Pin1 in Vivo
Pin1 selectively recognizes phosphorylated serine or threonine
immediately adjacent to a proline.9–11 Five putative consensus
motifs for Pin1 binding were identiﬁed on the SERCA2a
sequence (Figure S2A). SERCA2a includes Ser661-Pro662,
located in the cytoplasmic domain; and 4 Thr-Pro dipeptides (3
at 247/8, 499/500, and 537/8, located in cytoplasmic
domains, and 1 at 959/60, located in a luminal domain). One
putative consensus motif for Pin1 binding instead is present in
NCX-1 at Ser223-Pro224 (Figure S2B), which is located in the
extracellular domain. Thus, interaction of Pin1 with Ca2+ cycling
proteins SERCA2a and NCX-1 protein was evaluated by
proximity ligation assay in parafﬁn tissue sections from WT
hearts (Figure 4A and 4B). Proximity between Pin1 and
SERCA2a primary antibodies was detected as 4700 distinct
interactions compared with 10 events detected in control
sections stained with only 1 antibody (P<0.001; Figure 4A).
Furthermore, Pin1 and NCX-1 interaction events occurred in
2700 instances compared with only 18 events in single
antibody controls (P<0.001; Figure 4B). Pin1/ hearts used
as a negative control also exhibited a similarly low number of
events as single antibody negative control. These ﬁndings
demonstrate cellular in situ molecular interaction between Pin1
and calcium regulatory proteins SERCA2a and NCX-1.
Furthering the hypothesis that Pin1 activity inﬂuences
SERCA2a and NCX-1 protein expression, isolated
Figure 6. Ca2+ transient decay is delayed by peptidyl-prolyl isomerase 1 (Pin1) inhibition in vitro. A,
Superimposed traces of Ca2+ transient collected in cardiomyocytes treated for 2 hours with Pin1 inhibitor
juglone (1 lmol/L) or vehicle control (Ctrl). For each cell, an average trace of >10 beats is reported. B
through D, Ca2+ transient amplitude (B) and time to peak (TTP) (C) are unchanged in cardiomyocytes treated
with juglone compared with wild type (WT), but Ca2+ transient decay (D) is signiﬁcantly increased by Pin1
inhibition. Vehicle Ctrl (n=129) and juglone (n=144) from 3 WT hearts are shown. Data are presented as
median and interquartile ranges. F/F0, . *P<0.05 (Student t test).
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cardiomyocytes were pretreated for 2 hours with juglone, a
highly selective cell-permeable, irreversible inhibitor of
PPIases or water as vehicle control. SERCA2a or NCX-1
interaction with Pin1 is disrupted by juglone (Figure 5A and
5B, respectively). Moreover, SERCA2a and NCX-1 protein
levels were dose-dependently increased by Pin1 inhibition
(Figure 5C and 5D). In fact, treatment with only 10 nmol/L
juglone elevated SERCA2a levels by 1.8-fold (P<0.05; Fig-
ure 5C) and NCX-1 levels by 1.5-fold (P<0.001; Figure 5D)
compared with vehicle-treated controls. Treatment with a
higher juglone concentration of 1 lmol/L elevated SERCA2a
levels by 2.5-fold (P<0.001; Figure 5C) and NCX-1 levels by
1.9-fold (P<0.001; Figure 5D) compared with vehicle-treated
controls. SERCA2a and NCX-1 interaction was conﬁrmed by
pull-down assay (Figure S3). GST- and GST-Pin1–speciﬁc
protein expression was conﬁrmed by immunoblot against GST
proteins (Figure S3A). Immunoblot for SERCA2a and NCX-1
conﬁrmed speciﬁc interaction with Pin1, as for other known
targets (Figure S3B). Therefore, Pin1 protein interaction and/
or activity inﬂuences SERCA2a and NCX-1 protein expression,
with loss of Pin1 activity elevating SERCA2a and NCX-1
protein levels.
Cytosolic Ca2+ Removal Is Delayed by Pin1
Inhibition
Delayed Ca2+ decay correlates with impaired cardiomyocyte
relaxation, leading to reduced contractility.2,4 Interaction
between SERCA2a or NCX-1 and Pin1 to control cardiomy-
ocyte Ca2+ cycling was assessed by observing Ca2+ transients
after Pin1 inhibition by juglone. Representative superimposed
traces of Ca2+ transients collected from isolated cardiomyo-
cytes treated for 2h with Juglone or water as vehicle control
are shown in Figure 6A. Juglone pretreatment of cardiomy-
ocytes for 2 hours prompted signiﬁcant delay in Ca2+-
transient decay (Figure 6D), whereas Ca2+-transient ampli-
tude (Figure 6B) and time-to-peak Ca2+ transient (Figure 6C)
remained unchanged. These results support the regulatory
role of Pin1 in controlling cardiomyocyte Ca2+ cycling through
modulation of SERCA2a activity and/or expression.
Discussion
Ca2+ signals regulate cardiomyocyte contraction and multiple
critical cellular processes, including gene regulation, prolifer-
ation, enlargement, and death.2,4,27 The exact basis for how a
single ion precisely controls such diverse cellular processes
remains intriguing.27 However, there is consensus that the
magnitude and temporal signature of Ca2+ signal, as well as
the cellular localization of these signals, are critical for proper
cardiomyocyte function.27 Pin1 exhibits the unique property
of acting as a rheostat in the molecular signaling network to
regulate intensity and duration of signals.7,8 Findings in this
study deﬁne a novel role of Pin1 as a ﬁne-tuning mechanism
for regulation of Ca2+ dynamics through SERCA2a and NCX-1
proteins.
Decreased Ca2+ reuptake in cardiomyocytes causes
impaired myocardial relaxation and slows ﬁlling of the
ventricle, leading to HF with preserved ejection fraction.4,27
Results in this study showed that loss of Pin1 activity, by
either genetic deletion (Figure 1) or pharmacological inhibi-
tion (Figure 6), slows cytosolic Ca2+ clearance in isolated
cardiomyocytes. Reduced SERCA2a activity is also a charac-
teristic of HF.4,5 SR membranes isolated from Pin1-deﬁcient
hearts showed signiﬁcantly reduced SERCA2a Ca2+-ATPase
activity and uptake (Figure 3). Control of SERCA2a function
by Pin1 explains delayed Ca2+ clearance on Pin1 deletion or
pharmacological inhibition, substantiating a potential role for
Pin1 in contributing to dysregulation of Ca2+ homeostasis
associated with HF. Our ﬁndings agree with prior studies
reporting the pan PPIase inhibitor juglone inhibits SERCA2a
Ca2+-ATPase activity in isolated SR membranes.28 Decreased
Pin1 activity concomitant to acute or chronic stress, where
faster Ca2+ cycling is required to sustain increased contractile
function, could impair cardiac output and contribute to
progression of HF because of loss of inotropic responsive-
ness. SR ATPase activity and SR Ca2+ uptake were similarly
impaired in membranes isolated from Pin1+/ and Pin1/,
indicating that loss of 50% Pin protein level is sufﬁcient to
impair cardiac SERCA2a function. Results herein reveal
another facet of the Pin1 signaling in myocardial biological
features associated with regulation of Ca2+ handling within
cardiomyocytes. PPIase family members other than Pin1,
including cyclophylin D and FK-506–binding proteins, regulate
Ca2+ handling.14 Our ﬁndings expand known regulatory roles
for the PPIase family by incorporating the parvulin family
member Pin1 in regulation of Ca2+ handling within myocar-
dium via inﬂuences on SERCA2a and NCX-1.
This study reveals 2 novel targets regulating Ca2+ home-
ostasis in the myocardium inﬂuenced by Pin1: SERCA2a and
NCX-1 (Figures 4, 5, and S3). Pin1 has been associated with
calcium-dependent signaling through interaction with the Ca2+
regulator protein CaMKII in brain tissue, but whether CaMKII
function was affected by Pin1 binding remains unresolved.29
Our hypothesis is that Pin1 binding to SERCA2a and NCX-1
simultaneously inﬂuences both protein function and expres-
sion through simultaneous modiﬁcation of conformation and
protein turnover, respectively. Indeed, Pin1 might promote
stabilization in the active conformation of SERCA2a and NCX-
1 proteins, as for other targets, like b-catenin, nuclear factor
jB, and p53.9 In this scenario, Pin1 inhibition would impair
SERCA2a and NCX-1 function, which is partially compensated
by increased protein production within cardiomyocytes.
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Furthermore, Pin1 might also be important for SERCA2a and
NCX-1 protein turnover by decreasing stabilization, similar to
Pin1-mediated action on CF-2, c-Myc, and cyclin E.9 Conse-
quently, loss of Pin1 might slow SERCA2a and NCX-1
degradation, resulting in accumulation of protein. The com-
bined impact of SERCA2a- and NCX-1–impaired function,
coupled with protein accumulation resulting from diminished
Pin1, is consistent with our ﬁndings, as summarized in
Figure 7. In this model, Pin1 genetic deletion/inhibition
reduces overall SERCA2a and NCX-1 protein functional
activity, which is only partially compensated by protein
accumulation attributable to impaired SERCA2a and NCX-1
degradation. Future studies will investigate molecular mech-
anisms altering SERCA2a and NCX-1 function on Pin1 loss.
SERCA2a was phosphorylated by mass spectrometry in the
heart tissue at Ser38 and Ser661.30 Few studies have shown
that SERCA2a can be phosphorylated by CaMKII on Ser38,
enhancing enzyme activity.31 However, later studies using a
polyclonal antibody speciﬁc for the phosphorylated Ser38
epitope on the SERCA2a Ca2+ ATPase failed to detect the
phosphorylated form in both isolated cardiomyocytes and
puriﬁed SR vesicles. This suggested that Ser38 phosphoryla-
tion on SERCA2a is not a signiﬁcant regulatory feature of
SERCA2a activity.32 No studies have investigated potential
consequences of phosphorylation on Ser661 of SERCA2a.
NCX-1 was found, by mass spectrometry in the heart tissue,
phosphorylated on Ser389.30 However, no studies have
addressed the potential functional consequences of NCX-1
phosphorylation on these speciﬁc sites. Protein kinase C
phosphorylates NCX-1 in vivo, increasing exchange activity,
but the precise phosphorylation site has not been identiﬁed.33
Previous studies have identiﬁed phosphorylation on SERCA2a
and NCX-1 sites that are not in the putative consensus motifs
for Pin1 binding.30 However, the tryptic digestion performed
Figure 7. The impact of diminished peptidyl-prolyl isomerase 1 (Pin1) activity on cardiomyocyte Ca2+ handling. A, Pin1 binding to sarco
(endo)plasmic reticulum calcium ATPase (SERCA2a) and Na2+/Ca2+ exchanger 1 (NCX-1) promotes stabilization of active conformation for
SERCA2a and NCX-1 proteins as well as protein turnover to proteolytic machinery. B, Pin1 gene deletion or pharmacological inhibition impairs
SERCA2a and NCX-1 function, leading to increased compensatory protein production, together with diminished degradation of SERCA2a and
NCX-1 contributing to protein accumulation. ECM indicates extracellular membrane; LTCC, L-type Ca2+ channel; PLN, phospholamban; RyR2,
ryanodine receptor 2; and WT, wild type.
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before mass spectrometry analysis in this phosphoproteomic
study might have led to partial loss of information, leaving
phosphorylation sites located within the digested peptide
fragments. Further studies would be necessary to character-
ize if and under which conditions SERCA2a and NCX-1 are
phosphorylated at these motifs to allow Pin1 association.
Pin1 dysregulation is implicated in diverse pathological
conditions, including aging, immune response, neurodegener-
ative disease, and multiple cancers.7,10,11,34 Pin1 ubiquitous
expression controls homeostasis and growth through regula-
tion of cell proliferation, differentiation, and apoptosis in
diverse tissue types.9,11,34,35 Pin1 dual function in regulating
both cell signaling and protein folding accounts for why Pin1
expression levels vary widely between tissue types.10
Expression increases proportionally with cellular proliferative
capacity, and Pin1 levels are upregulated in most human
cancers.9–11,34 Pin1 controls cardiac progenitor cell prolifer-
ation through inﬂuence on cyclin D, cyclin B, p53, and
retinoblastoma.13 Pin1 deletion caused cell cycle arrest and
senescence, whereas Pin1 overexpression increases differen-
tiation and inhibits senescence of cardiac progenitor cells.13
In stark contrast, Pin1 is highly expressed in neurons from
onset of neuronal differentiation and decreases with aging,
suggesting Pin1 serves a completely different purpose in this
postmitotic cell context.10 A new layer of complexity has been
revealed by the overtly oppositional effect of Pin1 on
SERCA2a protein expression versus function.
In the myocardium, Pin1 serves a central modulator role
for pathological hypertrophy and ﬁbrosis.12,36,37 In the
myocardium, Pin1 controls hypertrophic growth through
regulation of Akt and Mitogen-activated protein kinase
(MEK).12 Either Pin1 genetic deletion or cardiac-speciﬁc
overexpression blunted hypertrophic responses induced by
transaortic constriction through modulation of different
pathways.12 Loss of Pin1 diminished hypertrophic signaling
of Akt and MEK, whereas overexpression of Pin1 increases
Rapidly Accelerated Fibrosarcoma serine/threonine-speciﬁc
protein kinases (Raf-1) phosphorylation on the autoinhibitory
site Ser259, leading to reduced MEK activation.12 In addition,
Pin1 inhibition by juglone attenuates cardiac extracellular
matrix deposition in a diabetic mouse model by regulating the
phosphorylation of Akt, transforming growth factor-b1, and
matrix metalloproteinases.36 Furthermore, juglone treatment
decreased transforming growth factor-b1 activity in the
promyelocytic leukemia nuclear bodies and hypertrophic
response in cardiac ﬁbroblasts challenged with arsenic
trioxide and angiotensin II,36 corroborating a role for Pin1 in
regulating myocardial hypertrophy. Delayed cytosolic Ca2+
reuptake, caused by Pin1 inhibition, could be at a subpatho-
logic level of disturbance. It could contribute to a prohyper-
trophic phenotype, with activation of cytosolic Ca2+ pathways
through the calcineurin-Nuclear Factor of Activated T cell
protein (NFAT) pathway and Ca2+-calmodulin–dependent
kinase Mitogen activated protein kinase Kinase (MEF2).1,38
In the latter case, overt lack of hypertrophic phenotype in Pin1
knockout mice might be maintained by the collective
inﬂuence of Pin1 on multiple regulatory cascade pathways
in parallel that collectively inﬂuence cell biological features.
Pin1 mediation of hypertrophic responsiveness is complex,
because cardiac-speciﬁc Pin1 overexpression blunted hyper-
trophic response induced by transaortic constriction by
inﬂuencing pathways different from those affected by Pin1
deletion.12 Preservation of homeostasis is consistent with
Pin1 acting as a rheostat on multiple concurrent pathways to
maintain optimal function. Cardiac-speciﬁc Pin1 overexpres-
sion could be explored as a molecular interventional strategy
to enhance SERCA2a activity and normalize Ca2+ homeostasis
within myocardial cells.
Acknowledgments
We thank Mansa Melvin and Julie Hu (University of Texas
Southwestern) for providing assistance with Pin1/ and Pin1+/
mice handling and transfer; Debora Eaton, Remus Berretta (Temple
University), and Dr Dong Sun (New York Medical College) for
technical support with isolated cardiomyocyte measurements; and all
the members of the Sussman laboratory for their critical feedback.
Sources of Funding
Sacchi was supported by Swiss National Found Fellowship
(P2BSP3_155252). Wang is supported by the Rees Stealy
Research Foundation Fellowship. Kubli is supported by NIH
grant F32 HL136064-01. Jin was supported by the American
Heart Association Postdoctoral Fellowship 16POST27510010.
Malter is supported byNIH grants P01HL088594. Glembotski is
supported by NIH grants R01 HL75573, R01 HL104535, R01
HL127439, and P01 HL085577. Sussman is supported by NIH
grants R01HL067245, R37HL091102, R01HL105759,
R01HL113647, R01HL117163, P01HL085577, and
R01HL122525, as well as an award from the Fondation Leducq.
Disclosures
Sussman is founder and co-owner of CardioCreate Inc. The
other authors report no conﬂicts.
References
1. van Berlo JH, Maillet M, Molkentin JD. Signaling effectors underlying pathologic
growth and remodeling of the heart. J Clin Invest. 2013;123:37–45.
2. Bers DM. Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol.
2008;70:23–49.
3. Gorski PA, Ceholski DK, Hajjar RJ. Altered myocardial calcium cycling and
energetics in heart failure: a rational approach for disease treatment. Cell
Metab. 2015;21:183–194.
DOI: 10.1161/JAHA.117.006837 Journal of the American Heart Association 12
Pin1 Controls Cardiomyocyte Ca2+ Dynamics Sacchi et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on June 20, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
4. Marks AR. Calcium cycling proteins and heart failure: mechanisms and
therapeutics. J Clin Invest. 2013;123:46–52.
5. Stammers AN, Susser SE, Hamm NC, Hlynsky MW, Kimber DE, Kehler DS,
Duhamel TA. The regulation of sarco(endo)plasmic reticulum calcium-ATPases
(SERCA). Can J Physiol Pharmacol. 2015;93:1–12.
6. Hobai IA, O’Rourke B. Decreased sarcoplasmic reticulum calcium content is
responsible for defective excitation-contraction coupling in canine heart
failure. Circulation. 2001;103:1577–1584.
7. Hariharan N, Sussman MA. Pin1: a molecular orchestrator in the heart. Trends
Cardiovasc Med. 2014;24:256–262.
8. Yaffe MB. Sequence-speciﬁc and phosphorylation-dependent proline isomer-
ization: a potential mitotic regulatory mechanism. Science. 1997;278:1957–
1960.
9. Lu KP, Zhou XZ. The prolyl isomerase PIN1: a pivotal new twist in
phosphorylation signalling and disease. Nat Rev Mol Cell Biol. 2007;8:904–916.
10. Driver JA, Zhou XZ, Lu KP. Pin1 dysregulation helps to explain the inverse
association between cancer and Alzheimer’s disease. Biochim Biophys Acta.
2015;1850:2069–2076.
11. Liou Y-C, Zhou XZ, Lu KP. Prolyl isomerase Pin1 as a molecular switch to
determine the fate of phosphoproteins. Trends Biochem Sci. 2011;36:501–514.
12. Toko H, Konstandin MH, Doroudgar S, Ormachea L, Joyo E, Joyo AY, Din S,
Gude NA, Collins B, V€olkers M, Thuerauf DJ, Glembotski CC, Chen CH, Lu KP,
M€uller OJ, Uchida T, Sussman MA. Regulation of cardiac hypertrophic signaling
by prolyl isomerase Pin1. Circ Res. 2013;112:1244–1252.
13. Toko H, Hariharan N, Konstandin MH, Ormachea L, McGregor M, Gude NA,
Sundararaman B, Joyo E, Joyo AY, Collins B, Din S, Mohsin S, Uchida T,
Sussman MA. Differential regulation of cellular senescence and differentiation
by prolyl isomerase Pin1 in cardiac progenitor cells. J Biol Chem.
2014;289:5348–5356.
14. Perrucci GL, Gowran A, Zanobini M, Capogrossi MC, Pompilio G, Nigro P.
Peptidyl-prolyl isomerases: a full cast of critical actors in cardiovascular
diseases. Cardiovasc Res. 2015;106:353–364.
15. Jaleel N, Nakayama H, Chen X, Kubo H, MacDonnell S, Zhang H, Berretta R,
Robbins J, Cribbs L, Molkentin JD, Houser SR. Ca2+ inﬂux through T- and L-
type Ca2+ channels have different effects on myocyte contractility and induce
unique cardiac phenotypes. Circ Res. 2008;103:1109–1119.
16. Signore S, Sorrentino A, Ferreira-Martins J, Kannappan R, Shafaie M, Del Ben F,
Isobe K, Arranto C, Wybieralska E, Webster A, Sanada F, Ogorek B, Zheng H,
Liu X, Del Monte F, D’Alessandro DA, Wunimenghe O, Michler RE, Hosoda T,
Goichberg P, Leri A, Kajstura J, Anversa P, Rota M. Inositol 1, 4,
5-trisphosphate receptors and human left ventricular myocytes. Circulation.
2013;128:1286–1297.
17. Signore S, Sorrentino A, Borghetti G, Cannata A, Meo M, Zhou Y, Kannappan R,
Pasqualini F, O’Malley H, Sundman M, Tsigkas N, Zhang E, Arranto C,
Mangiaracina C, Isobe K, Sena BF, Kim J, Goichberg P, Nahrendorf M, Isom LL,
Leri A, Anversa P, Rota M. Late Na(+) current and protracted electrical
recovery are critical determinants of the aging myopathy. Nat Commun.
2015;6:8803.
18. Kubli DA, Cortez MQ, Moyzis AG, Najor RH, Lee Y, Gustafsson AB. PINK1 is
dispensable for mitochondrial recruitment of parkin and activation of
mitophagy in cardiac myocytes. PLoS One. 2015;10:e0130707.
19. S€oderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius K-J, Jarvius J,
Wester K, Hydbring P, Bahram F, Larsson L-G, Landegren U. Direct observation
of individual endogenous protein complexes in situ by proximity ligation. Nat
Methods. 2006;3:995–1000.
20. Zieba A, W€ahlby C, Hjelm F, Jordan L, Berg J, Landegren U, Pardali K. Bright-
ﬁeld microscopy visualization of proteins and protein complexes by in situ
proximity ligation with peroxidase detection. Clin Chem. 2010;56:99–110.
21. Din S, Mason M, V€olkers M, Johnson B, Cottage CT, Wang Z, Joyo AY, Quijada
P, Erhardt P, Magnuson NS, Konstandin MH, Sussman MA. Pim-1 preserves
mitochondrial morphology by inhibiting dynamin-related protein 1 transloca-
tion. Proc Natl Acad Sci USA. 2013;110:5969–5974.
22. Volkers M, Toko H, Doroudgar S, Din S, Quijada P, Joyo AY, Ornelas L, Joyo E,
Thuerauf DJ, Konstandin MH, Gude N, Glembotski CC, Sussman MA.
Pathological hypertrophy amelioration by PRAS40-mediated inhibition of
mTORC1. Proc Natl Acad Sci USA. 2013;110:12661–12666.
23. O’Brien PJ. Calcium sequestration by isolated sarcoplasmic reticulum: real-
time monitoring using ratiometric dual-emission spectroﬂuorometry and the
ﬂuorescent calcium-binding dye indo-1. Mol Cell Biochem. 1990;94:113–119.
24. Tupling R, Green H, Senisterra G, Lepock J, McKee N. Effects of 4-h ischemia
and 1-h reperfusion on rat muscle sarcoplasmic reticulum function. Am J
Physiol Endocrinol Metab. 2001;281:867–877.
25. Duhamel TA, Green HJ, Stewart RD, Foley KP, Smith IC, Ouyang J. Muscle
metabolic, SR Ca(2+) -cycling responses to prolonged cycling, with and
without glucose supplementation. J Appl Physiol. 2007;103:1986–1998.
26. Baik SH, Fane M, Park JH, Cheng YL, Fann DYW, Yun UJ, Choi Y, Park JS, Chai
BH, Park JS, Back SH, Jeong JI, Jang YJ, Bahn G, Lee JY, Li YI, Sobey CG, Uchida
T, Park JH, Kim HT, Tang SC, Arumugam TV, Jo DG. Pin1 promotes neuronal
death in stroke by stabilizing notch intracellular domain. Ann Neurol.
2015;77:504–516.
27. Aronsen JM, Louch WE, Sjaastad I. Cardiomyocyte Ca2+ dynamics: clinical
perspectives. Scand Cardiovasc J. 2016;50:65–77.
28. Floreani M, Forlin A, Bellin S, Carpenedo F. Structure-activity relationship for
the inhibition of cardiac sarcoplasmic reticulum Ca2+ ATPase activity by
naphthoquinones. Biochem Mol Biol Int. 1995;37:757–763.
29. Tatara Y, Terakawa T, Uchida T. Identiﬁcation of Pin1-binding phosphorylated
proteins in the mouse brain. Biosci Biotechnol Biochem. 2010;74:2480–2483.
30. Huttlin EL, Jedrychowski MP, Elias JE, Goswami T, Rad R, Beausoleil SA, Villen
J, Haas W, Sowa ME, Gygi SP. A tissue-speciﬁc atlas of mouse protein
phosphorylation and expression. Cell. 2010;143:1174–1189.
31. Toyofuku T, Curotto Kurzydlowski K, Narayanan N, MacLennan DH. Identiﬁ-
cation of Ser38 as the site in cardiac sar- coplasmic reticulum Ca2+-ATPase
that is phosphorylated by Ca2+/calmodulin-dependent protein kinase. J Biol
Chem. 1994;269:26492–26496.
32. Rodriguez P, Jackson WA, Colyer J. Critical evaluation of cardiac Ca2+-ATPase
phosphorylation on serine 38 using a phosphorylation site-speciﬁc antibody. J
Biol Chem. 2004;279:17111–17119.
33. Iwamoto T, Pan Y, Wakabayashi S, Imagawa T, Yamanaka H, Shigekawa M.
Phosphorylation-dependent regulation of cardiac Na+/Ca2+ exchanger via
protein kinase C. J Biol Chem. 1996;271:13609–13615.
34. Lin C-H, Li H-Y, Lee Y-C, Calkins MJ, Lee K-H, Yang C-N, Lu P-J. Landscape of
Pin1 in the cell cycle. Exp Biol Med. 2015;240:403–408.
35. Sorrentino G, Comel A, Mantovani F, Del Sal G. Regulation of mitochondrial
apoptosis by Pin1 in cancer and neurodegeneration. Mitochondrion.
2014;19:88–96.
36. Liu YY-X, Zhao D, Qiu F, Zhang L-L, Liu S-K, Li Y-Y, Liu M-T, Wu D, Wang J-X,
Ding X-Q, Liu YY-X, Dong C-J, Shao X-Q, Yang B-F, Chu W-F. Manipulating PML
SUMOylation via silencing UBC9 and RNF4 regulates cardiac ﬁbrosis. Mol
Ther. 2017;25:666–678.
37. Liu X, Liang E, Song X, Du Z, Zhang Y, Zhao Y. Inhibition of Pin1 alleviates
myocardial ﬁbrosis and dysfunction in STZ-induced diabetic mice. Biochem
Biophys Res Commun. 2016;479:109–115.
38. Zarain-Herzberg A, Fragoso-Medina J, Estrada-Aviles R. Calcium-regulated
transcriptional pathways in the normal and pathologic heart. IUBMB Life.
2011;63:847–855.
DOI: 10.1161/JAHA.117.006837 Journal of the American Heart Association 13
Pin1 Controls Cardiomyocyte Ca2+ Dynamics Sacchi et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on June 20, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
  
 
 
SUPPLEMENTAL MATERIAL 
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 Table S1. Antibody list. 
Use: Western 
Blot 
Company Primary antibody 
dilution 
Secondary antibody 
dilution  
Goat anti-
SERCA2a  
Santa Cruz 
Biotechnology 
(sc-8095) 
1:1000 Donkey anti-goat 680 
1:5000 (925-68074) 
Rabbit anti NCX-
1 
Santa Cruz 
Biotechnology 
(sc-30304) 
1:500 Donkey anti-rabbit 800 
1:5000 (925-32213) 
Rabbit anti-
CamKII 
ThermoFisher 
(PA5-39732)  
1:500 Donkey anti-rabbit 800 
1:5000 (925-68074) 
Rabbit anti-
pCamKII 
Thermofisher 
(PA5-39731) 
1:500 Donkey anti-rabbit 800 
1:5000 (925-68074) 
Rabbit anti-LTCC Alomone Labs 
(ACC-003) 
1:500 Donkey anti-rabbit 800 
1:5000 (925-68074) 
Rabbit anti-LTCC 
(pSer 1928) 
Badrilla (A010-70)  1:250 Donkey anti-rabbit 800 
1:5000 (925-68074) 
Rabbit anti-RYR2  Millipore (AB9080) 1:500 Donkey anti-rabbit 800 
1:5000 (925-68074) 
Rabbit anti- 
RYR2 
(pSer2814) 
Badrilla  
(A010-31) 
1:1000 Donkey anti-rabbit 800 
1:5000 (925-68074) 
Rabbit anti-RYR2 
(pSer2808) 
Badrilla  
(A010-30) 
1:3000 Donkey anti-rabbit 800 
1:5000 (925-68074) 
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 Mouse anti-PLN Thermofisher 
(MA3-922) 
1:1000 Donkey anti-mouse 680 
1:5000 (925-68072) 
Rabbit anti-PLN 
(pSer16) 
Badrilla  
(A010-12AP) 
1:1000 Donkey anti-rabbit 800 
1:5000 (925-68074) 
Rabbit anti-PLN 
(pThr17) 
Badrilla (A010-13) 1: 3000 Donkey anti-rabbit 800 
1:5000 (925-68074) 
Goat anti-
GAPDH 
SICGEN (AB0067-
200) 
1:10000 Donkey anti-goat 680 
1:5000 (925-68074) 
Rabbit anti-GST Cell Signaling 
Technology 
(#2622) 
1:500 Donkey anti- rabbit 800 
1:5000 (925-68074) 
Use: PLA on 
Paraffin 
Sections 
Company Primary antibody 
dilution 
Secondary antibody 
dilution 
Goat anti-MYL2 Santa Cruz 
Biotechnology  
(sc-34490) 
1:50 Donkey anti-goat 1:200 
(A11055) 
Mouse anti-
SERCA2a 
Thermofisher 
(MA3-919) 
1:50 N/A 
Mouse anti-NCX-
1 
Thermofisher  
(MA3-926) 
1:50 N/A 
Rabbit anti-Pin1 Santa Cruz 
Biotechnology (sc-
15340) 
1:20 N/A 
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 Use: PLA on 
fixed 
cardiomyocyte 
Company Primary antibody 
dilution 
Secondary antibody 
dilution 
Goat anti-MYL2 Santa Cruz 
Biotechnology  
(sc-34490) 
1:100 Donkey anti-goat 1:200 
(A11055) 
Mouse anti-
SERCA2a 
Thermofisher 
(MA3-919) 
1:100 N/A 
Mouse anti-NCX-
1 
Thermofisher  
(MA3-926) 
1:100 N/A 
Rabbit anti-Pin1 Santa Cruz 
Biotechnology (sc-
15340) 
1:50 N/A 
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 Figure S1. pCamKII/CamKII (A), pLTCC/LTCC(B), pPLN (Ser16 and Thr 17)/PLN (C) and 
pRyR2 (Ser2808 and Ser2814)/RyR2 (D) expression and phosphorylation levels are 
unaltered in Pin1 deficient hearts. Phosphorylated Ca2+/Calmodulin-dependent kinase II 
(pCamKII)/CamKII (A), phosphorylated L-type Ca2+ channel (LTCC)/LTCC(B), phosphorylated 
Phospholamban (PLN) (Ser16 and Thr 17)/PLN (C) and pRyR2 (Ser2808 and Ser2814)/RyR2 
expression and phosphorylation levels are unaltered in Peptidyl Prolyl Isomerase (Pin1)+/- and 
Pin1-/- hearts compared to wild-type (WT) by immunoblot analysis. GAPDH used as loading 
control. Quantitation of protein expression shown below each representative blot as n-fold 
expression/WT. Data presented as mean±SEM, N=4.  
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 Figure S2. Putative consensus motifs for Pin1 binding on SERCA2a and NCX-1 protein 
sequences identified by in silico analysis. (A) sarco(endo)plasmic reticulum calcium ATPase 
(SERCA2a) sequence accession number NP_033852.1 (murine; NCBI protein database) or (B) 
Na2+/Ca2+ exchanger 1 (NCX-1) sequence accession number NP_035536.2 (murine; NCBI 
protein database) analyzed for serine next to a proline residue (black squares) or threonine next 
to a proline (red squares).  
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 Figure S3 SERCA2a and NCX-1 physically interact with GST-Pin1  
(A) Immunoblot for Glutathione S-Transferase (GST) (left) and GST-Pin1 (right) showing GST 
and GST-Pin1 protein expression at 25 and 45 kDa respectively. (B) Na2+/Ca2+ exchanger 1 
(NCX-1) and sarco(endo)plasmic reticulum calcium ATPase (SERCA2a) interacted with GST-
Pin1 but not with GST upon pull-down as shown by immunoblot. β-catenin and AKT were used 
as positive control for the pull-down since are known targets of Pin1. N=3 
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